Immunotherapy with Keytruda (Pembolizumab) Doctors Abroad — Page 2

Head of Medical Oncology at Sourasky Medical Center – Dr. Wolf leads a top-tier oncology division specializing in advanced treatments.

• Specializes in oncology with extensive experience in immunotherapy
• Degree from Ben Gurion University – trained in cutting-edge oncology protocols
• Fluent in English for clear patient communication
• Background includes Army Medical Units – handles complex cases

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Head of Neurooncology Clinic at Sourasky Medical Center (Ichilov) – specializes in advanced cancer treatments.

• Leads a dedicated team for neurooncology cases
• Focuses on innovative therapies like immunotherapy
• Works at one of Israel's top medical centers

Director of oncology hospitalization at Tel Aviv Medical Center, Ichilov – Dr. Stepfansky brings extensive clinical and research expertise to immunotherapy cases.

• Over 26 years of experience of experience in oncology and internal medicine
• Actively involved in Phase I-III clinical trials for new cancer treatments
• Specialized training in oncology from Tel Aviv Medical Center, Ichilov
• Holds multiple research roles in cutting-edge immunotherapy studies

Director of children's hematology oncology at Sourasky Medical Center, specializing in bone cancer (sarcoma) and blood disorders.

• Senior pediatrician at Children's Hospital 'Dana'
• Specializes in pediatric hematology and oncology
• Member of the Israeli association ISPHO
• Studied oncology bone and soft tissue in Italy's Rizzoli Orthopaedic Institute

Dr. Fredi Aviv brings 34 years of experience of oncohematology expertise to immunotherapy treatments at Sourasky Medical Center (Ichilov Clinic).

• Specializes in hematologic oncology and immunotherapy
• Practices at a leading medical center in Israel
• Extensive experience with cutting-edge cancer treatments

Dr. Yair specializes in hematology with a focus on chronic lymphocytic leukemia – recognized with multiple awards for his research and clinical excellence.

• Recipient of the Klitzberg Oncology Award and other prestigious honors
• Member of both Israeli and American Hematology Associations
• Trained at top medical centers in Israel
• Published extensively in hematology research

Dr. Sonnenblick Amir specializes in targeted therapies for breast cancer, including immunotherapy with Keytruda (Pembolizumab). He's recognized with multiple awards for his contributions to oncology research.

• ESMO Breast Cancer Translational and Clinical Research Fellowship at Jules Bordet Institute
• Over 30 presentations at national and international scientific meetings
• Recipient of the ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)

Specializes in immunotherapy for tumor diseases, with expertise in Keytruda (Pembrolizumab). Recognized for molecular biology research in cancer treatment.

• Chief Physician at certified interdisciplinary cancer center BKZ Solingen
• Active member of American Association for Cancer Research
• Specializes in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics
• Works closely with leading haematologists

Dr. Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers, bringing focused expertise to immunotherapy treatments.

• Associate Professor since 2016
• Experienced across multiple oncology departments in Turkey
• Graduated from Selcuk University's Faculty of Medicine

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Alemdar specializes in immunotherapy with Keytruda at Medical Park Antalya Hospital Complex, bringing extensive experience in medical oncology.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital, a leading medical institution

Dr. Auala Hubert brings 36 years of experience of expertise in oncology and radiotherapy at Hadassah Medical Center, specializing in immunotherapy.

• Heads the Gastrointestinal Cancer Center – deep expertise in complex cases
• Trained at Hadassah University Hospital – one of Israel's leading oncology centers
• Active member of multiple cancer research and treatment committees

Dr. Ozden brings over 27 years of experience of medical oncology experience to his role at VM Medical Park Pendik Hospital.

• Specialized in Medical Oncology at Kocaeli University
• Graduated from Istanbul University's English Medical Program
• Worked across multiple hospitals specializing in internal medicine

Associate Professor Muhammed Mustafa Atci specializes in medical oncology at İstinye University Liv Hospital Topkapı, with a strong focus on immunotherapy treatments.

• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Education Coordinator for Medical Oncology Sub-Branch
• Extensive experience in treating various cancer types with immunotherapy

Professor Cicin specializes in immunotherapy at İstinye University Liv Hospital Topkapı, with over 29 years of experience in medical oncology.

• Fellowship-trained in medical oncology at Trakya University
• Professor at Trakya University Faculty of Medicine
• Extensive experience in treating cancer patients with immunotherapy

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.